1113 results about "Aminal" patented technology

A quaternary ammonium salt detergent made from the reaction product of the reaction of: (a) a hydrocarbyl substituted acylating agent and a compound having an oxygen or nitrogen atom capable of condensing with said acylating agent and further having a tertiary amino group; and (b) a quaternizing agent suitable for converting the tertiary amino group to a quaternary nitrogen and the use of such quaternary ammonium salt detergents in a fuel composition to reduce intake valve deposits.

The present invention concerns a method to detect the presence of an enzyme in in vivo or in vitro tissue or cell, which method comprises:(a) obtaining a tissue or cell sample to be analyzed;(b) contacting the tissue or cell sample with a substrate of the structure selected from the group consisting of:X=H or one or more natural or synthetic amino acids with or without amino blocking groups,Y=H or one or more natural or synthetic amino acids with or without amino blocking groups,wherein X and Y are the same or different and are amino acid sequences of between about 1 to 1,000,000 amino acids wherein each amino acid is the same or a different amino acid, with the proviso that at least one of X or Y is at least one amino acid;(c) when an enzyme is present in the tissue or cell sample which degrades X, Y and combinations thereof, fluorescent cresyl violet is released in the tissue sample producing a color change;(d) detecting the presence and amount of the enzyme present by the detection and quantification of the fluorescence produced; and(e) optionally comparing the fluorescence to a pre-calibrated fluorescence scale to quantify the fluorescence present. A diagnostic kit for use and a method to prepare amino acid cresyl violet derivatives are described.

Electrophotographic photoreceptor having a photosensitive layer containing an amino compound selected from formulae 1 to 22 in the specification.

A method of and a solution for making a highly porous optical antireflection coating of a selectively designed index of refraction, by applying a colloidal dispersion derived from hydrolytically condensing, in the presence of water and a catalyst, one or more silicon compounds of the general formula RaSiX4-a, or precondensates derived therefrom, to a substrate. In the formula, R is an organic group having from 1 to 10 carbon atoms which may be interrupted by oxygen atoms and/or sulfur atoms and/or amino groups, X is hydrogen, halogen, hydroxy, alkoxy, acyloxy, alkylcarbonyl, alkoxycarbonyl or NR'2, R' being hydrogen, alkyl or aryl and a being 0, 1 or 2. The solution also contains colloidally dispersed organic polymers at a molar ratio, relative to the silane, between 0.1 mmol/mol silane and 100 mmol/mol silane, the median molecular mass of the polymer being between 200 and 500,000. Sol-vents, preferably alcohol, may also be present in the solution. After being applied to an optical substrate, the solution is dried and organic components are removed from it to leave a porous coating of predetermined index of refraction.

An organic luminescence device is constituted by a pair of an anode and a cathode, and at least one organic luminescence function layer disposed between the anode and the cathode. At least one organic luminescence function layer described above includes a layer of a fused polynuclear compound represented by the following formula (I): wherein R1, R2, R3 and R4 independently denote hydrogen atom, an alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic group, a substituted amino group or cyano group; and Ar1 and Ar2 independently denote a substituted or unsubstituted fused polynuclear aromatic group or a substituted or unsubstituted fused polynuclear heterocyclic group.

The invention has an object of safely and simply preparing a large amount of a ruthenium metathesis catalyst, which is used as a catalyst for a carbon-carbon bond formation using, particularly, a metathesis reaction. The metathesis catalyst has the following complex composition (A) or (B). The composition (A) includes RuX12(arene)(PR1R2R3) and R4CHX22, R5C=CH or R4CHX2 and a reducing agent, wherein X1 and X2 respectively are a halogen atom; arene is a hydrocarbon having a benzene ring; R1, R2 and R3, which may be the same or different, respectively are an alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-8 carbon atoms or an optionally substituted aryl group, wherein the substituent group is an alkyl group having 1-8 carbon atoms, an alkoxy group having 1-8 carbon atoms, an alkylamino group having 1-8 carbon atoms or a halogen atom; R4 is an alkyl group which has 1-8 carbon atoms and may have an ether bond or an ester bond, an optionally subsituted aryl group, wherein the substituent group is a halogen atom or a hydroxyl group; or cycloalkyl group having 3-8 carbon atoms; and R5 is an optionally substituted alkyl group which has 1-8 carbon atoms and may have an ether bond or an ester bond, wherein the substituent group is a halogen atom or a hydroxyl group, an aryl group or a cycloalkyl group having 3-8 carbon atoms. The composition B includes [RuX12(arene)]2, PR1R2R3, R5C=CH or R4CHX2 and a reducing agent, wherein X1, arene, R1, R2, R3, R4 and R5 are the same as defined above.

The invention discloses an iridium complex phosphor material taking a phthalazine derivative as a ligand. The structure of the material is shown as formulas (I) and (II), wherein Ar represents aryl, substituted aryl, heterocycle aryl and substituted heterocycle aryl; R can be one of a halogen atom, alkyl, substituted alkyl, alkoxyl, aryloxy, an alkylthio group, arylthio, aromatic amino, aliphatic amino or a heterocyclic substituent; L^Y can be one of N-COOH, 8-hydroxyquinoline, beta-diketone, N^NH and the like; N^N can be bipyridyl, diquinoline, 1,10-phenanthroline, a derivative of the 1,10-phenanthroline and the like; and Z can be hexafluorophosphate and perchlorate. A dicyclic or ionic iridium complex phosphorescent electroluminescent device taking the phthalazine derivative as the ligand obtained with the preparation method has high internal and external quantum yields, high luminance and high stability. A dicyclic iridium complex is shown as a formula (I), i.e., (C^N)2Ir(L^Y); and an ionic iridium complex is shown as a formula (II), i.e., (C^N)2Ir(N^N)<+>Z<->.

The invention relates to a water-soluble chitosan quaternary ammonium salt antibiotic finishing agent. The invention is characterized in that the antibiotic finishing agent is names as O-methacrylamide-N-hydroxypropyl alkyl dimethyl ammonium chloride chitosan and the concrete structural formula is as follows. The preparation thereof includes that: alkyl dimethyl tertiary amide and epichlorohydrin are taken as raw materials to synthesize 2, 3-epoxy alkyl dimethyl ammonium chloride, then the 2, 3-epoxy alkyl dimethyl ammonium chloride is introduce onto the ammonium group of chitosan, so as to obtain N-hydroxypropyl alkyl dimethyl ammonium chloride chitosan HDCC, and then crosslinking is carried out on the HDCC and hydroxymethyl acrylamide is carried out, thus obtaining NMA-HDCC. The quaternary ammonium salt antibiotic finishing agent contains water-soluble group and fibrous reactivity group and has good water solubility, the bacterial inhibition rate of finished cotton fabrics is close to 100%, and the finishing agent can be combined with cellulose fiber by covalent bond and is wash-resistant; and cost is low, raw material is environmental friendly, environmental pollution is less, thus having industrialization application prospect.

For certain mixed mode resins having anionic character, a ligand is joined to a solid support via a linkage that includes a mercapto-, ether- or amino-containing moiety. A suitable ligand comprises an aromatic group, a heteroaromatic group, or a heterocyclic group, optionally fused, that is sulfate-, sulfonate-, phosphonate- or phosphate-substituted and that is linked to such a moiety. These resins possess an anionic character under conditions prescribed for their use. Separation of a biological substance, such as a peptide or protein, can be accomplished with a resin of this type via a change in the pH of eluants, thereby effecting adsorption and desorption.

This invention relates to curcumin analogs and their applications. Curcumin is an excellent precursor compound, and has multiple pharmaceutical activities. The curcumin analogs in this invention have more stable monocarbonyl intermediate connection chain structure. The connection chain can be acetone, cyclopentanone or cyclohexanone. The substituent on benzene ring can be separately selected from H, hydroxyl, halogen, alkoxyl, alkyl, halogenated alkyl, amino, and alkyl amino. This invention also discloses pharmaceutically acceptable salts of the curcumin analogs, preparations containing them, and their pharmaceutical applications. Experiments show that the curcumin analogs can be used to treat inflammation and tumor.

The invention discloses a production method of L-glufosinate. The method includes the steps that with 2-carbonyl-4-(hydroxyl methyl phosphoryl) butyric acid and salt thereof being a substrate, isolated transaminase or a cell catalysis substrate of in-vitro expression transaminase reacts with an amino donor under the condition that the amino donor exists, so that L-glufosinate is obtained, wherein the amino donor is alanine, and the amino acid sequence of transaminase is shown in SEQ ID NO.1-3. With 2-carbonyl-4-(hydroxyl methyl phosphoryl) butyric acid and salt thereof being the substrate and alanine being the amino donor, the transamination reaction occurs through the specific transaminase catalysis substrate, the substrate can be completely converted into L-glufosinate, and the conversion rate of raw materials is high and can reach 100%.

The present invention discloses synthesis of 2,2′-disubstituted 9,9′-spirobifluorene-based triaryldiamine. First, 2,2′-diamino-9,9′-spirobifluorene, a Pd-catalyst as auxiliary and aryl halide BX are provided, wherein X is selected from the group consisting of: Cl, Br and I, B comprises one of the following group: aryl moiety, hetero cycle, multiple fused ring, multiple fused ring with hetero atom(s). Next, a substitution reaction is performed to react the 2,2′-diamino-9,9′-spirobifluorene with the aryl halide BX to produce the 2,2′-disubstituted 9,9′-spirobifluorene-based triaryldiamines. In addition, the present invention discloses organic light emitting devices comprising hole transporting material comprising 2,2′-bis(N,N-disubstituted amino)-9,9′-spirobifluorenes.

Primary intermediates useful hair coloring systems comprise quaternized pyrrolidine compounds. The invention provides new quaternized pyrrolidine of Formula (1): wherein X is Cl, Br, I, or R3 SO4; R is a C1 to C22 alkyl group or a C1 to C22 mono or dihydroxyalkyl group; R1 and R2 are each independently a C1 to C4 alkyl group; R3 is a C1 to C22 alkyl group or a C1 to C22 mono or dihydroxyalkyl group; R4 is a hydrogen atom, a C1 to C5 alkyl group or such an alkyl group substituted with one or more hydroxy or amino moieties; and R5 is a hydrogen atom or a hydroxy group.

An cross-linked anion exchange resin or a salt thereof obtained by reacting a polymer (A) having amino and/or imino groups in the total number of two or more per molecule with a compound (B) having two or more functional groups capable of reacting with amino and/or imino group contained in the polymer (A). The resin or salt has a water absorption ratio of 4.0 or lower.

A lubricant composition suitable for fuel injected two-stroke cycle engines includes an oil of lubricating viscosity, an amount, sufficient to reduce or prevent piston scuffing, of a mixture of (A) at least one phenol selected from (A-1) an aminophenol and (A-2) a reaction product of a nitrophenol and an amino compound, and (B) at least one Mannich dispersant, amine dispersant, nitrogen-containing carboxylic dispersant, or ester dispersant. The composition further includes an amount, sufficient to reduce degradation of the lubricant composition upon exposure to oxygen or oxides of nitrogen, of a nitrogen-containing inhibitor, a hindered phenol inhibitor, or a sulfur-containing organic inhibitor.

The invention relates to a series of polyglycoside derivatives that contain water-soluble groups introduced into the molecule by reaction with the hydroxyl groups present in the starting polyglycoside molecule. The preferred products have more than one water-soluble group per molecule and are made with mild reagents to avoid discoloration and mal odor. The most preferred products have between 2 and 3 functional groups per molecule. The compounds are amino functional and betaine functional alkyl polyglucoside.